Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Angiotensin I-converting enzyme (CD143) is down-regulated in focal nodular hyperplasia of the liver.

Gräntzdörffer I, Lendeckel U, Carl-McGrath S, Roessner A, Röcken C.

Am J Surg Pathol. 2004 Jan;28(1):84-8.

PMID:
14707868
2.

Ectopeptidases are differentially expressed in hepatocellular carcinomas.

Röcken C, Carl-McGrath S, Gräntzdörffer I, Mantke R, Roessner A, Lendeckel U.

Int J Oncol. 2004 Mar;24(3):487-95.

PMID:
14767532
3.

A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.

Paradis V, Bièche I, Dargère D, Laurendeau I, Nectoux J, Degott C, Belghiti J, Vidaud M, Bedossa P.

Gastroenterology. 2003 Mar;124(3):651-9.

PMID:
12612904
4.

The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.

Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, Bioulac-Sage P, Zucman-Rossi J.

J Hepatol. 2008 Jul;49(1):61-71. doi: 10.1016/j.jhep.2008.03.013. Epub 2008 Apr 18.

5.

Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.

Paradis V, Benzekri A, Dargère D, Bièche I, Laurendeau I, Vilgrain V, Belghiti J, Vidaud M, Degott C, Bedossa P.

Gastroenterology. 2004 May;126(5):1323-9.

PMID:
15131793
6.

Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment.

Herman P, Pugliese V, Machado MA, Montagnini AL, Salem MZ, Bacchella T, D'Albuquerque LA, Saad WA, Machado MC, Pinotti HW.

World J Surg. 2000 Mar;24(3):372-6.

PMID:
10658075
7.

Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.

Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, Yen Y, Weiss LM, Chu PG.

Am J Surg Pathol. 2008 Mar;32(3):433-44. doi: 10.1097/PAS.0b013e318158142f.

PMID:
18300806
8.

[Expression of CD143 and its significance in focal nodular hyperplasia of liver].

Shi L, Jiang LL, Liu WP, Tang Y.

Zhonghua Bing Li Xue Za Zhi. 2006 Jul;35(7):421-2. Chinese. No abstract available.

PMID:
17069679
9.

Use of X-chromosome inactivation pattern and laser microdissection to determine the clonal origin of focal nodular hyperplasia of the liver.

Gong L, Li YH, Su Q, Li G, Zhang WD, Zhang W.

Pathology. 2009;41(4):348-55. doi: 10.1080/00313020902885029.

PMID:
19404847
11.

Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.

Gouysse G, Frachon S, Hervieu V, Fiorentino M, d'Errico A, Dumortier J, Boillot O, Partensky C, Grigioni WF, Scoazec JY.

J Hepatol. 2004 Aug;41(2):259-66.

PMID:
15288475
12.

Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.

Bioulac-Sage P, Laumonier H, Rullier A, Cubel G, Laurent C, Zucman-Rossi J, Balabaud C.

Liver Int. 2009 Mar;29(3):459-65. doi: 10.1111/j.1478-3231.2008.01849.x. Epub 2008 Sep 18.

PMID:
18803590
13.

Extranodular background liver parenchyma of focal nodular hyperplasia: histopathological characteristics.

Motosugi U, Murata S, Shimizu M, Yasuda M, Sakurai T, Shimizu Y, Ban S, Nagata K, Yamaguchi H, Sannohe S.

Virchows Arch. 2009 May;454(5):557-62. doi: 10.1007/s00428-009-0743-9. Epub 2009 Apr 22.

PMID:
19387683
14.
15.

Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.

Ahmad I, Iyer A, Marginean CE, Yeh MM, Ferrell L, Qin L, Bifulco CB, Jain D.

Hum Pathol. 2009 May;40(5):726-34. doi: 10.1016/j.humpath.2008.10.018. Epub 2009 Jan 20.

PMID:
19157505
16.

Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection.

Mounajjed T, Wu TT.

Am J Surg Pathol. 2011 Sep;35(9):1356-63. doi: 10.1097/PAS.0b013e31822280f3.

PMID:
21836491
17.

Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.

Di Gioia S, Bianchi P, Destro A, Grizzi F, Malesci A, Laghi L, Levrero M, Morabito A, Roncalli M.

BMC Cancer. 2006 Apr 10;6:89.

18.

[Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].

DU JL, Wei LX, Wang YL.

Zhonghua Bing Li Xue Za Zhi. 2011 Jan;40(1):11-6. Chinese.

PMID:
21429352
19.

Focal nodular hyperplasia after orthotopic liver transplantation.

Ra SH, Kaplan JB, Lassman CR.

Liver Transpl. 2010 Jan;16(1):98-103. doi: 10.1002/lt.21956.

20.

Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver.

Bioulac-Sage P, Rebouissou S, Sa Cunha A, Jeannot E, Lepreux S, Blanc JF, Blanché H, Le Bail B, Saric J, Laurent-Puig P, Balabaud C, Zucman-Rossi J.

Gastroenterology. 2005 May;128(5):1211-8.

PMID:
15887105

Supplemental Content

Support Center